Table 5 The Committee’s and the sample ranking of technologies accepted by the 2006/7 Basket Committee (monthly cost threshold = 250 NIS)
Technology | Rank Basket Committee | Diagonal | Rank survey - Total | Rank survey - Physicians | Rank survey - Members of the Basket Committee | Rank efficiencya |
|---|---|---|---|---|---|---|
Crestor Ezetrol | 1 | 1 | 15 | 15 | 15 | 9 |
Atacand Ocsaar Diovan Olmetec | 2 | 2 | 15 | 15 | 15 | 2 |
Lantus Levemir | 3 | 3 | 12 | 12 | 10 | 4 |
Apidra Humalog Novorapid | 4 | 4 | 15 | 15 | 15 | 7 |
Eloxatin | 5 | 5 | 10 | 10 | 10 | 3 |
Xeloda | 6 | 6 | 10 | 10 | 10 | 1 |
Herceptin | 7 | 7 | 8 | 8 | 9 | 15 |
Hepsera | 8 | 8 | 2 | 2 | 2 | 12 |
Viread | 9 | 9 | 7 | 5 | 7 | 14 |
Prevnar | 10 | 10 | 18 | 18 | 18 | 18 |
Mabthera | 11 | 11 | 1 | 1 | 1 | 11 |
Keppra | 12 | 12 | 13 | 13 | 14 | 5 |
Zyprexa | 13 | 13 | 14 | 14 | 13 | 17 |
Exjade | 14 | 14 | 4 | 3 | 3 | 13 |
Plavix (cardiac) | 15 | 15 | 5 | 5 | 4 | 8 |
Growth hormon | 16 | 16 | 9 | 9 | 8 | 10 |
Plavix (stroke) | 17 | 17 | 5 | 5 | 4 | 6 |
Velcade | 18 | 18 | 3 | 4 | 4 | 16 |